XML 40 R17.htm IDEA: XBRL DOCUMENT v3.3.0.814
Lines of Business
9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Lines of Business
Lines of Business

Our Animal Hospital and Laboratory business segments are each considered reportable segments in accordance with the FASB's guidance related to Segment Reporting. Our Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Our Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with our animal hospitals and those independent of us. Our other operating segments included in the “All Other” category are our Medical Technology business, which sells digital radiography and ultrasound imaging equipment, related computer hardware, software and ancillary services to the veterinary market, our Vetstreet business, which provides online and printed communications, professional education, marketing solutions to the veterinary community and an ecommerce platform for independent animal hospitals, and our Camp Bow Wow business, which primarily franchises a premier provider of pet services including dog day care, overnight boarding, grooming and other ancillary services at specially designed pet care facilities. These operating segments do not meet the quantitative requirements for reportable segments. Our operating segments are strategic business units that have different services, products and/or functions. The segments are managed separately because each is a distinct and different business venture with unique challenges, risks and rewards. We also operate a corporate office that provides general and administrative support services for our other segments.
The accounting policies of our segments are the same as those described in the summary of significant accounting policies included in our 2014 Annual Report on Form 10-K. We evaluate the performance of our segments based on gross profit and operating income. For purposes of reviewing the operating performance of our segments, all intercompany sales and purchases are generally accounted for as if they were transactions with independent third parties at current market prices.
8. Lines of Business, continued

The following is a summary of certain financial data for each of our segments (in thousands):

 
Animal
Hospital
 
Laboratory
 
All Other
 
Corporate
 

Eliminations
 
Total
Three Months Ended
September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
External revenue
$
441,924

 
$
84,129

 
$
24,544

 
$

 
$
1,120

 
$
551,717

Intercompany revenue

 
16,180

 
6,294

 

 
(22,474
)
 

Total revenue
441,924

 
100,309

 
30,838

 

 
(21,354
)
 
551,717

Direct costs
366,983

 
48,901

 
19,077

 

 
(20,910
)
 
414,051

Gross profit
74,941

 
51,408

 
11,761

 

 
(444
)
 
137,666

Selling, general and administrative expense
10,677

 
9,542

 
7,660

 
16,981

 

 
44,860

Operating income (loss) before sale or disposal of assets
64,264

 
41,866

 
4,101

 
(16,981
)
 
(444
)
 
92,806

Business interruption insurance gain

 

 
(4,523
)
 

 

 
(4,523
)
Net loss on sale or disposal of assets
175

 

 
72

 
3

 

 
250

Operating income (loss)
$
64,089

 
$
41,866

 
$
8,552

 
$
(16,984
)
 
$
(444
)
 
$
97,079

Depreciation and amortization
$
16,520

 
$
2,731

 
$
1,181

 
$
588

 
$
(549
)
 
$
20,471

Property and equipment additions
$
19,429

 
$
5,735

 
$
127

 
$
2,773

 
$
(1,115
)
 
$
26,949

Three Months Ended
September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
External revenue
$
395,820

 
$
77,394

 
$
25,397

 
$

 
$
966

 
$
499,577

Intercompany revenue

 
14,509

 
4,684

 

 
(19,193
)
 

Total revenue
395,820

 
91,903

 
30,081

 

 
(18,227
)
 
499,577

Direct costs
327,283

 
46,879

 
19,945

 

 
(18,287
)
 
375,820

Gross profit
68,537

 
45,024

 
10,136

 

 
60

 
123,757

Selling, general and administrative expense
9,269

 
8,610

 
8,023

 
16,890

 

 
42,792

Operating income (loss) before sale or disposal of assets
59,268

 
36,414

 
2,113

 
(16,890
)
 
60

 
80,965

Impairment of goodwill and other long-lived assets

 

 
27,019

 

 

 
27,019

Net loss (gain) on sale or disposal of assets
598

 
7

 

 
(135
)
 

 
470

Operating income (loss)
$
58,670


$
36,407

 
$
(24,906
)
 
$
(16,755
)
 
$
60

 
$
53,476

Depreciation and amortization
$
15,201

 
$
2,671

 
$
1,781

 
$
688

 
$
(479
)
 
$
19,862

Property and equipment additions
$
17,224

 
$
2,391

 
$
1,123

 
$
2,025

 
$
(649
)
 
$
22,114









8. Lines of Business, continued

 
Animal
Hospital
 
Laboratory
 
All Other
 
Corporate
 

Eliminations
 
Total
Nine Months Ended
September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
External revenue
$
1,270,326

 
$
252,645

 
$
73,895

 
$

 
$
3,089

 
$
1,599,955

Intercompany revenue

 
47,858

 
19,839

 

 
(67,697
)
 

Total revenue
1,270,326

 
300,503

 
93,734

 

 
(64,608
)
 
1,599,955

Direct costs
1,066,516

 
144,410

 
59,160

 

 
(62,506
)
 
1,207,580

Gross profit
203,810

 
156,093

 
34,574

 

 
(2,102
)
 
392,375

Selling, general and administrative expense
32,351

 
27,894

 
24,088

 
49,410

 

 
133,743

Operating income (loss) before charges
171,459

 
128,199

 
10,486

 
(49,410
)
 
(2,102
)
 
258,632

Business interruption insurance gain

 

 
(4,523
)
 

 

 
(4,523
)
Net (gain) loss on sale or disposal of assets
(445
)
 
41

 
92

 
78

 

 
(234
)
Operating income (loss)
$
171,904

 
$
128,158

 
$
14,917

 
$
(49,488
)
 
$
(2,102
)
 
$
263,389

Depreciation and amortization
$
49,032

 
$
7,940

 
$
3,509

 
$
1,755

 
$
(1,602
)
 
$
60,634

Property and equipment additions
$
45,506

 
$
11,813

 
$
1,427

 
$
5,349

 
$
(2,625
)
 
$
61,470

Nine Months Ended
September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
External revenue
$
1,134,184

 
$
233,497

 
$
68,055

 
$

 
$
2,820

 
$
1,438,556

Intercompany revenue

 
42,895

 
13,859

 

 
(56,754
)
 

Total revenue
1,134,184

 
276,392

 
81,914

 

 
(53,934
)
 
1,438,556

Direct costs
953,511

 
139,245

 
54,161

 

 
(53,984
)
 
1,092,933

Gross profit
180,673

 
137,147

 
27,753

 

 
50

 
345,623

Selling, general and administrative expense
28,261

 
24,909

 
23,782

 
47,211

 

 
124,163

Operating income (loss) before charges
152,412

 
112,238

 
3,971

 
(47,211
)
 
50

 
221,460

Impairment of goodwill and other long-lived assets

 

 
27,019

 

 

 
27,019

Net loss (gain) on sale or disposal of assets
1,180

 
(71
)
 
(1,087
)
 
(195
)
 

 
(173
)
Operating income (loss)
$
151,232

 
$
112,309

 
$
(21,961
)
 
$
(47,016
)
 
$
50

 
$
194,614

Depreciation and amortization
$
45,053

 
$
7,769

 
$
5,921

 
$
2,333

 
$
(1,417
)
 
$
59,659

Property and equipment additions
$
38,411

 
$
5,676

 
$
2,801

 
$
4,769

 
$
(1,564
)
 
$
50,093

 
 
 
 
 
 
 
 
 
 
 
 
At September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
Total assets
$
2,147,136

 
$
304,807

 
$
76,969

 
$
391,471

 
$
(489,193
)
 
$
2,431,190

At December 31, 2014
 
 
 
 
 
 
 
 
 
 
 
Total assets
$
2,021,725

 
$
258,550

 
$
89,596

 
$
270,414

 
$
(308,265
)
 
$
2,332,020